Physician profile
Hope D Shipman
NPI 1932170719
$1,703.88
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,570 · 2021: $134.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valeritas, INC. | $284.52 | 2019 | |
| Sanofi-Aventis U.S. LLC | $212.20 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $155.75 | 2019 | |
| Abbott Laboratories | $134.34 | 2021 | |
| Novo Nordisk INC | $134.33 | 2019 | |
| Insulet Corporation | $85.34 | 2019 | |
| Lilly USA, LLC | $85.03 | 2019 | |
| Corcept Therapeutics | $69.74 | 2019 | |
| Medtronic Minimed, INC. | $64.03 | 2019 | |
| Amgen INC. | $50.41 | 2019 | |
| Ibsa Pharma INC. | $49.55 | 2019 | |
| Mannkind Corporation | $49.30 | 2019 | |
| Shire North American Group INC | $47.63 | 2019 | |
| Abbvie INC. | $40.81 | 2019 | |
| Amarin Pharma, INC. | $39.50 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $39.48 | 2019 | |
| Radius Health, INC. | $35.04 | 2019 | |
| Dexcom, INC. | $23.88 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.56 | 2019 | |
| Companion Medical, INC. | $21.08 | 2019 | |
| Tandem Diabetes Care, INC. | $18.20 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $15.11 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.68 | 2019 | |
| Amneal Pharmaceuticals LLC | $11.37 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hope Shipman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.